about
Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health scienceMolecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseRed Meat and Colorectal CancerMolecular phenotypes of colorectal cancer and potential clinical applicationsSerrated lesions of the colorectum: review and recommendations from an expert panelEtiologic field effect: reappraisal of the field effect concept in cancer predisposition and progressionImmune escape mechanisms in colorectal cancer pathogenesis and liver metastasisDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyAspirin use, tumor PIK3CA mutation, and colorectal-cancer survivalMolecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysisAge-specific prevalence of serrated lesions and their subtypes by screening colonoscopy: a retrospective studyProgressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals.Tumor location as a novel high risk parameter for stage II colorectal cancers.Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial.Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancerProceedings of the second international molecular pathological epidemiology (MPE) meetingEpigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations.Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality.Pattern of distant metastases in colorectal cancer: a SEER based study.Estrogen receptors and their implications in colorectal carcinogenesis.Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers.Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort.Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancerSomatic gene mutations in African Americans may predict worse outcomes in colorectal cancer.Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principleA Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study.BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics.Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohortsThe critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level.Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision.
P2860
Q24289208-476565C0-B8E6-48DF-8964-4F3CB5D27916Q24289344-4CDAAF11-A8B5-46F4-BF2D-1304AA6BE5A5Q26771416-3EC0B76C-DA35-4DCD-8622-E0302C1C4020Q26785725-B6D0AF58-3990-4190-BD0E-2DBA7157042AQ26827208-15C38934-A7BA-430D-992F-132716A063CAQ26852716-DE88C49C-0E6C-4719-A38C-738CCE71E7C6Q27002388-E4FAD888-13E8-47C2-848F-7DE379B0503EQ27011884-FAB4EC5F-D7D3-44D2-A658-A2F18E9C51BBQ28277824-D6F3255A-0623-4A2A-9510-EFF1C2316CE5Q30244608-988447E3-06C8-436A-BB42-065EFA562DA6Q30248900-C8775E14-8855-412B-AF52-D55A125C13E1Q33611163-C92B3A47-7AD1-40B8-B201-0CED58D1C519Q33812820-42D0B945-2ECF-41B7-BA0D-D9318E9603DAQ33828917-E8E8FEE9-16E2-46B9-B7CA-B38FF502DB4AQ34016833-3CE1A582-C6EC-477B-8245-5F3BC18BC17FQ34038277-CAA11AE3-4AF5-42BF-97E0-E632215EE85AQ34169734-9ABEC1D7-97DF-4B48-B6C3-92255D3B223DQ34266707-791EBFD3-456E-4A9B-954A-0FFB69833E0FQ34450525-D2C3E4B3-F193-4D30-92C8-83F72C667A3AQ34475686-E011C314-D5A2-4903-8128-79BCE9F3CC6EQ34487177-A66E3338-1AE2-4C03-AC25-0D46EC9CF690Q34502713-81AA66DB-B4CD-4FAD-BE68-CB8EAFF295D8Q34598203-F3151DC1-2210-4387-86B8-BBBDFABF1850Q34656265-D139E1BF-EC14-49F0-8897-D219CF4017C8Q34674089-491902B9-7E9D-4F2F-BC5C-50E40015AA31Q35037282-0FCF82B9-3CC8-4437-B662-20728DB1DA5CQ35130874-7BABA87A-99E8-47C1-97B9-5706A33C0A37Q35137525-3A13AC3C-CCCC-4501-922E-456B997F7329Q35677169-342E0B2D-6F7B-41D3-A48C-497D5A719246Q35956384-1FFD50EC-6636-4B1C-B82A-35C9752893D9Q36001973-5A1DFA54-6345-4129-8C57-5A4F7D989A26Q36108299-D0B25A38-4156-4222-B2AA-02949C819967Q36195885-D5E61C52-4E8A-4F78-85FB-D7B48045F11EQ36245897-5DB96D7F-DA9C-4DE1-8C7E-570421A31390Q36306276-AD774901-0B7E-426E-8339-D02C42F1A0C2Q36405847-2C0FDFE9-43ED-4A20-93C0-DD035BBAE09EQ36510909-9F5E34FD-5038-4A6A-B051-CB6AD83C5473Q36535688-934C9D3F-4036-4557-80BC-C0BC061AD55AQ36675320-CC54A203-1621-4ABA-855E-5374E3E7544DQ36688767-86C95E96-A936-440B-BEFB-BC282529F279
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Colorectal cancer: a tale of two sides or a continuum?
@ast
Colorectal cancer: a tale of two sides or a continuum?
@en
type
label
Colorectal cancer: a tale of two sides or a continuum?
@ast
Colorectal cancer: a tale of two sides or a continuum?
@en
prefLabel
Colorectal cancer: a tale of two sides or a continuum?
@ast
Colorectal cancer: a tale of two sides or a continuum?
@en
P2093
P2860
P50
P1433
P1476
Colorectal cancer: a tale of two sides or a continuum?
@en
P2093
Andrew T Chan
Mai Yamauchi
Paul Lochhead
Shuji Ogino
Teppei Morikawa
P2860
P304
P356
10.1136/GUTJNL-2012-302014
P407
P577
2012-04-05T00:00:00Z